Show results for
Refine by
Cancer Patients Software In France
5 software items found
by:Moovcare, By Sivan Innovation LTD based inParis, FRANCE
Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients. A Class I medical device, Moovcare has been proven in clinical trials to improve overall survival by 7.6 ...
by:Sivan Innovation LTD based inParis, FRANCE
Moovcare® is the first digital therapeutics reimbursed in France! Moovcare® defines a new reality in cancer follow-up, by empowering patients with symptoms management and providing the medical team a reliable digital tool to monitor their patients. Symptoms management is essential from a psychological and physical point of view when ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling ...